Showing results (141-150 of 150) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2011
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinomaJ A Chan, L S Blaszkowsky, P C Enzinger, et al.Journal of the National Cancer Institute|May 30, 1998
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genesJ S Brunet, P Ghadirian, T R Rebbeck, et al.The New England Journal of Medicine|January 18, 1996
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancerM G FitzGerald, D J MacDonald, M Krainer, et al.Biotechnology and Bioengineering|March 29, 2023
A CHO stable pool production platform for rapid clinical development of trimeric SARS-CoV-2 spike subunit vaccine antigensSimon Joubert, Matthew Stuible, Simon Lord-Dufour, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer riskT S Frank, S A Manley, O I Olopade, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II studyH S Han, V Diéras, M Robson, et al.Journal of Medical Genetics|October 6, 2010
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancersK A Schrader, S Masciari, N Boyd, et al.ESMO Real World Data and Digital Oncology|February 6, 2026
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)A Acebedo, P L Bedard, S Brown, et al.Nature Communications|March 14, 2023
An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicityNina E Weisser, Mario Sanches, Eric Escobar-Cabrera, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2022
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancerC E Geyer, J E Garber, R D Gelber, et al.Pageof 15